Crossmark

Efficacy and safety of perioperative immunotherapy combinations for resectable non-small cell lung cancer: a systematic review and network meta-analysis

Crossref DOI link: https://doi.org/10.1007/s00262-024-03844-w

Published Online: 2024-10-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Han, Yuelin

Xiao, Xiangtian

Qin, Tingting

Yao, Shuxi

Liu, Xinyue

Feng, Yanqi

Li, Zhou

Li, Yiming

Xia, Shu
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82172716)

Beijing Xisike Clinical Oncology Research Foundation (Y-HR2020MS-0924)
License Information

Text and Data Mining valid from 2024-10-09

Version of Record valid from 2024-10-09
More Information

Article History

Received: 8 July 2024

Accepted: 22 September 2024

First Online: 9 October 2024

Declarations

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below